Marko Gjorgjevski

Dr. Marko Gjorgjevski

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Brain Stimulation
Verified
Journal Article
Open access
JWJosefine Waldthaler
Josefine Waldthaler
MBMiriam Bopp
Miriam Bopp
NKNele Kühn
Nele Kühn
BBBugrahan Bacara
Bugrahan Bacara
MKMerle Keuler
Merle Keuler
DPDavid J. Pedrosa
David J. Pedrosa
The need for imaging-guided optimization of Deep Brain Stimulation (DBS) parameters is increasing with recent developments of sophisticated lead designs offering highly individualized, but time-consuming and complex programming. The objective of this study was to compare changes in motor symptoms of Parkinson's Disease (PD) and the corresponding volume of the electrostatic field (VEsF) achieved by DBS programming using GUIDE XT™, a commercially available software for visualization of DBS leads within the patient-specific anatomy from fusions of preoperative magnetic resonance imaging (MRI) and postoperative computed tomography (CT) scans, versus standard-of-care clinical programming. Clinical evaluation was performed to identify the optimal set of parameters based on clinical effects in 29 patients with PD and bilateral directional leads for Subthalamic Nucleus (STN) DBS. A second DBS program was generated in GUIDE XT™ based on a VEsF optimally located within the dorsolateral STN. Reduction of motor symptoms (Movement Disorders Society Unified Parkinson's Disease Rating Scale, MDS-UPDRS) and the overlap of the corresponding VEsF of both programs were compared. Clinical and imaging-guided programming resulted in a significant reduction in the MDS-UPDRS scores compared to off-state. Motor symptom control with GUIDE XT™-derived DBS program was non-inferior to standard clinical programming. The overlap of the two VEsF did not correlate with the difference in motor symptom reduction by the programs. Imaging-guided programming of directional DBS leads using GUIDE XT™ is possible without computational background and leads to non-inferior motor symptom control compared with clinical programming. DBS programs based on patient-specific imaging data may thus serve as starting point for clinical testing and may promote more efficient DBS programming.

23 May 2024 in Cancers
Verified
Journal Article
Open access
PDF file
Miriam H. A. BoppMiriam H. A. Bopp
Miriam H. A. Bopp
AGAlexander Grote
Alexander Grote
MGMarko Gjorgjevski
Marko Gjorgjevski
Mirza PojskicMirza Pojskic
Mirza Pojskic
BSBenjamin Saß
Benjamin Saß
Christopher NimskyChristopher Nimsky
Christopher Nimsky
Despite its broad use in cranial and spinal surgery, navigation support and microscope-based augmented reality (AR) have not yet found their way into posterior fossa surgery in the sitting position. While this position offers surgical benefits, navigation accuracy and thereof the use of navigation itself seems limited. Intraoperative ultrasound (iUS) can be applied at any time during surgery, delivering real-time images that can be used for accuracy verification and navigation updates. Within this study, its applicability in the sitting position was assessed. Data from 15 patients with lesions within the posterior fossa who underwent magnetic resonance imaging (MRI)-based navigation-supported surgery in the sitting position were retrospectively analyzed using the standard reference array and new rigid image-based MRI-iUS co-registration. The navigation accuracy was evaluated based on the spatial overlap of the outlined lesions and the distance between the corresponding landmarks in both data sets, respectively. Image-based co-registration significantly improved (p < 0.001) the spatial overlap of the outlined lesion (0.42 ± 0.30 vs. 0.65 ± 0.23) and significantly reduced (p < 0.001) the distance between the corresponding landmarks (8.69 ± 6.23 mm vs. 3.19 ± 2.73 mm), allowing for the sufficient use of navigation and AR support. Navigated iUS can therefore serve as an easy-to-use tool to enable navigation support for posterior fossa surgery in the sitting position.

12 February 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
AGAlexander Grote
Alexander Grote
MGMarko Gjorgjevski
Marko Gjorgjevski
BCBarbara Carl
Barbara Carl
DDDaniel Delev
Daniel Delev
SKSusanne Knake
Susanne Knake
Miriam H. A. BoppMiriam H. A. Bopp
Miriam H. A. Bopp
Background: Pharmacoresistant epilepsy affects approximately one-third of all epilepsy patients, and resective surgery may offer favorable outcomes for carefully selected patients with focal epilepsy. The accurate identification of the epileptogenic zone (EZ) is essential for successful surgery, particularly in cases where non-invasive diagnostics are inconclusive. Invasive diagnostics with stereoelectroencephalography (SEEG) offer a reliable approach to localizing the EZ, especially in MRI-negative cases. Methods: This retrospective study analyzed the data of 22 patients with pharmacoresistant epilepsy who underwent frameless stereotactic SEEG electrode implantation with automated CT-based registration between September 2016 and November 2024. For measuring accuracy, Euclidean distance, radial deviation, angular deviation, and depth deviation were calculated for each electrode. Results: A total of 153 depth electrodes were implanted, targeting various cortical regions. The median Euclidean distance at the entry point was 1.54 mm (IQR 1.31), with a radial deviation of 1.33 mm (IQR 1.32). At the target level, the median Euclidean distance was 2.61 mm (IQR 1.53), with a radial deviation of 1.67 mm (IQR 1.54) and depth deviation of 0.95 mm (IQR 2.43). Accuracy was not significantly affected by electrode order, anatomical location, skull thickness, or intracranial length. Conclusions: These findings demonstrate that frameless stereotactic SEEG electrode implantation is safe and feasible for identifying the EZ. The integration of automatic intraoperative CT-based registration ensures precision. While maintaining workflow efficiency, it achieves accuracy comparable to frame-based methods. Further studies with larger cohorts are warranted to validate these results and assess their impact on surgical outcomes.

26 August 2025 in Sensors
Verified
Journal Article
Open access
PDF file
FNFranziska Neumann
Franziska Neumann
AGAlexander Grote
Alexander Grote
MGMarko Gjorgjevski
Marko Gjorgjevski
BCBarbara Carl
Barbara Carl
SKSusanne Knake
Susanne Knake
Miriam H. A. BoppMiriam H. A. Bopp
Miriam H. A. Bopp
Mesial temporal lobe epilepsy (mTLE) surgery, particularly selective amygdalohippocampectomy (sAHE), is a recognized treatment for pharmacoresistant temporal lobe epilepsy (TLE). Accurate intraoperative orientation is crucial for complete resection while maintaining functional integrity. This study evaluated the usability and effectiveness of multimodal neuronavigation and microscope-based augmented reality (AR) with intraoperative computed tomography (iCT) and navigated intraoperative ultrasound (iUS) in 28 patients undergoing resective surgery. Automatic iCT-based registration provided high initial navigation accuracy. Navigated iUS was utilized to verify navigational accuracy and assess the extent of resection during the procedure. AR support was successfully implemented in all cases, enhancing surgical orientation, surgeon comfort, and patient safety, while also aiding training and education. At one-year follow-up, 60.7% of patients achieved complete seizure freedom (ILAE Class 1), rising to 67.9% at the latest follow-up (median 4.6 years). Surgical complications were present in three cases (10.7%), but none resulted in permanent deficits. The integration of microscope-based AR with iCT and navigated iUS provides a precise and safe approach to resection in TLE surgery, additionally serving as valuable tool for neurosurgical training and education.